Search
Technetium Tc-99m tilmanocept
go.drugbank.com/drugs/DB09266ApprovedDue to its relatively small molecular weight and small molecular diameter of 7 nm [A32168], technetium Tc-99m tilmanocept displays more rapid injection site clearance, high sentinel node extraction, and
Formebolone
go.drugbank.com/drugs/DB01569IllicitInvestigationalFormebolone, a derivative of androstane, is an anabolic androgenic steroid. It is on the list of substances prohibited by the Word Anti-Doping Agency, and is regularly screened for in athletes.
Mycobacterium w. Vaccine
go.drugbank.com/drugs/DB15798InvestigationalAs an immunotherapy, M.w is used against leprosy; the compound also shares antigens with M. tuberculosis.
UCB7362
go.drugbank.com/drugs/DB17096ExperimentalUCB7362 is an orally active plasmepsin X (PMX) inhibitor currently investigated for the treatment of malaria.
Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine
go.drugbank.com/drugs/DB15813InvestigationalSpecifically, the COVID-19 infection relies on the binding of the Spike protein to an ACEII receptor, and with the described approach, the vaccine uses these engineered minigenes to express viral proteins
Medetomidine
go.drugbank.com/drugs/DB11428ExperimentalVet approvedMedetomidine is an intravenously available alpha-2 adrenergic agonist. The drug has been developed by Orion Pharma.
Distigmine
go.drugbank.com/drugs/DB13694InvestigationalIt is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors.
Etravirine
go.drugbank.com/drugs/DB06414ApprovedInvestigationalEtravirine is an antiretroviral agent more specifically classified as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI).
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesAX200
go.drugbank.com/drugs/DB05093InvestigationalAX200, which has been developed for the treatment of stroke, is the most advanced drug candidate and is halfway through the process of gaining clinical approval. The expression of the endogenous AX200 protein in the brain is increased af...